NOTICE OF ALLOWANCE - ISSUED
issued
on 28 Nov 2023
Last Applicant/ Owned by
Baarerstrasse 14
ZUG V8 SWITZERLAND
CH
6300
Serial Number
97461144 filed on 16th Jun 2022
Registration Number
N/A
Correspondent Address
Tiffany D. Gehrke
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
VCTX212
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development VCTX TWO ONE TWO; VCTX TWO HUNDRED TWELVE VCTX 212 Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulatio Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
Class [005]
Pharmaceutical Products
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes
Mark Details
Serial Number
No 97461144
Mark Type
No Service Mark
Attorney Docket Number
No 33324/60060
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Nov 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 03rd Oct 2023 | PUBLISHED FOR OPPOSITION |
| 03rd Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 13th Sep 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 25th Aug 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 27th Jul 2023 | ASSIGNED TO LIE |
| 27th Jul 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 27th Jul 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 03rd Jul 2023 | ASSIGNED TO EXAMINER |
| 20th Mar 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |